NALIRIFOX Combined With PD-1 Sequential Radiotherapy Versus AG Combined With PD-1 Sequential Radiotherapy as First-line Treatment of Locally Advanced Pancreatic Cancer

Clinical trial NCT06494514 · RECRUITING

Trial details

NCT number: NCT06494514
Sponsor: Du Juan
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Cancer

Start date: 2024-04-01
Primary completion: 2027-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.